Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cholestasis: later-stage trial registry
A small indexed set (7 trials) with no open enrollment listed right now.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · none currently recruiting · #2,497 of 28,707 conditions by registered trial count
Cholestasis: 7 US clinical trials tracked, none currently recruiting.
Cholestasis is the subject of 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 3 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Mirum Pharmaceuticals, running 1 of these trials.
Enrollment posture brief
Registry condition cholestasis
OPEN 0 | RECR 0% | LATE 3 | EARLY 1 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Cholestasis has no open enrollment in this registry pull (7 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cholestasis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cholestasis is recruiting below its size-band peers.
0 of 7 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cholestasis trials is spread across many organizations.
Mirum Pharmaceuticals accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Cholestasis enrolment sits around 85 participants.
Median target enrolment is 85 among the 7 trials that report a genuine target (sentinel values excluded). 4 of those (57.1%) plan for fewer than 100 participants.
-
Cholestasis research is mostly interventional.
6 interventional and 1 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
7 total, page 1 of 1
Linerixibat Long-term Safety, and Tolerability Study
GlaxoSmithKline
NCT04167358
Osmotic Fragility in Red Blood Cells of Pediatric Patients With Cholestatic Liver Disease
Children's Hospital Medical Center, Cincinnati
NCT05582447
Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in Infants
Baylor College of Medicine
NCT00738101
Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis
University of Michigan
NCT00004414
Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid
Mirum Pharmaceuticals
NCT00007020
Cholestasis Prevention: Efficacy of IV Fish Oil
Boston Children's Hospital
NCT00512629
Gabapentin to Treat Itch in Patients With Liver Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00058890
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Cholestasis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cholestasis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cholestasis page
7 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Cholestasis trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Mirum Pharmaceuticals sponsors the most Cholestasis trials on record, review their full trial history before evaluating a specific study. See Mirum Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cholestasis condition card totals 7 registered trials; most-linked intervention Omegaven; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.